TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA…

TELA Bio Strengthens Team with 10,200 Share Incentive Package for 14 Strategic New Hires

TELA Bio grants equity incentives to expand medical technology team. See how the company structures retention packages for key talent. Learn more.

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Arcutis Biotherapeutics

Open the article to view the coverage from Arcutis Biotherapeutics